GPT and renal pelvis/ureter urothelial carcinoma: Multiple studies and meta-analyses have demonstrated that an elevated AST/ALT ratio portends adverse oncologic outcomes across various urologic cancers; our findings add to this body of evidence by specifically evaluating patients with UTUC who develop bladder tumor recurrences after RNU [21].